Antheia
Antheia specializes in producing biosynthetic key starting materials (KSMs) and active pharmaceutical ingredients (APIs) for essential medicines using synthetic biology. By engineering yeast to reconstruct complex biosynthetic pathways, the company converts simple sugars into pharmaceutical compounds through fermentation. This approach aims to reduce reliance on traditional agricultural sources and chemical synthesis, offering a more controlled and consistent supply chain. Antheia's product pipeline includes compounds for therapeutic areas such as neurology, oncology, and gastroenterology. The company supports pharmaceutical partners from development through regulatory submission to facilitate the adoption of biomanufactured ingredients.
Domain
antheia.bio
Country
United StatesIndustry
BiotechnologyEmployees
11-50
Last Funding
$24.0M
Founded
2014
Tech Stack (28 technologies)
Frequently Asked Questions
What technologies does Antheia use?+
Antheia uses 28 technologies including Elementor, Flying Pages, Google Analytics.
What industry is Antheia in?+
Antheia operates in the Biotechnology industry.
Where is Antheia based?+
Antheia is headquartered in United States.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026